The arteriotomy closure devices market size has grown strongly in recent years. It will grow from $1.72 billion in 2025 to $1.84 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing volume of catheter-based interventions, wider adoption of minimally invasive angiography procedures, growth in cardiovascular disease prevalence, improved clinical acceptance of closure devices, expansion of interventional cardiology services.
The arteriotomy closure devices market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for next-generation vascular closure solutions, rising focus on reducing procedure-related complications, expansion of outpatient vascular procedures, growing investments in bioresorbable materials, increasing adoption of advanced closure technologies. Major trends in the forecast period include increasing adoption of suture-based closure devices, rising preference for radial access closure solutions, growing use of bioabsorbable hemostatic materials, expansion of minimally invasive vascular procedures, enhanced focus on faster patient recovery.
The rising prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the arteriotomy closure devices market in the coming years. CVDs encompass a range of disorders that impact the heart and blood vessels. The growing incidence of CVDs is primarily due to increasing risk factors such as poor diets, lack of physical activity, obesity, and an aging population. Arteriotomy closure devices play a critical role in cardiovascular procedures by efficiently sealing arterial puncture sites, reducing the risk of complications, and enhancing recovery after treatments such as angioplasties and catheterizations. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research organization, reported that around 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. This number is expected to rise by an additional 1 million by 2030 and may increase by up to 2 million by 2040. As a result, the growing prevalence of cardiovascular diseases is driving the expansion of the arteriotomy closure devices market.
Leading companies in the arteriotomy closure devices market are focusing on innovation to improve procedural efficiency, enhance patient outcomes, and address the growing demand for minimally invasive vascular access solutions. A mid-bore venous closure device is a medical instrument designed to close venous access sites created by medium-sized catheters or sheaths, helping with hemostasis and supporting patient recovery after interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare firm, expanded its VASCADE product line by introducing the VASCADE MVP XL mid-bore venous closure device. This device is designed for larger sheaths (10-12F, up to 15F outer diameter) commonly used in procedures such as cryoablation. It features 58% more collagen and a bigger collapsible disc to facilitate rapid hemostasis. This addition to Haemonetics' portfolio of small- and mid-bore vascular closure solutions highlights the company’s leadership in advanced closure technology.
In January 2025, Kalteq Group, a Greece-based medical device distributor, entered into an exclusive partnership with Teleflex. Through this partnership, Kalteq Group will distribute the MANTA Vascular Closure Device in Greece, broadening access to advanced large-bore femoral arterial closure solutions that enhance procedural efficiency and patient outcomes. Teleflex, Inc. is a U.S.-based company that provides arteriotomy closure devices.
Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical.
North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the arteriotomy closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the arteriotomy closure devices market by increasing costs of imported medical polymers, bioabsorbable materials, precision manufacturing tools, and sterile packaging components. Hospitals and ambulatory care centers in North America and Europe are most affected due to dependence on imported device components, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are increasing procedural costs and device pricing pressures. However, they are also encouraging domestic production, localized supply chains, and innovation in cost-effective vascular closure solutions.
The arteriotomy closure devices market research report is one of a series of new reports that provides arteriotomy closure devices market statistics, including arteriotomy closure devices industry global market size, regional shares, competitors with a arteriotomy closure devices market share, detailed arteriotomy closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the arteriotomy closure devices industry. This arteriotomy closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An arteriotomy closure device (ACD) is a specialized medical tool intended to seal the puncture site in an artery after procedures such as catheterization or angiography. It helps achieve hemostasis by closing the artery, minimizing the risk of bleeding, and promoting a quicker recovery compared to manual compression. ACDs are frequently employed in minimally invasive vascular procedures to improve both patient safety and the efficiency of the procedure.
Arteriotomy closure devices primarily come in two types, active closure devices and passive closure devices. Active closure devices are used to close arterial puncture sites following medical procedures, employing mechanical or mechanical-hemostatic techniques to stop bleeding and support faster recovery. These devices are used in various procedures, including those involving femoral and radial arterial access, and are employed by a variety of healthcare settings, such as hospitals, outpatient care centers, and other medical facilities.
The arteriotomy closure devices market consists of sales of angiograms, catheterizations, and other interventional surgeries. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The arteriotomy closure devices market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for next-generation vascular closure solutions, rising focus on reducing procedure-related complications, expansion of outpatient vascular procedures, growing investments in bioresorbable materials, increasing adoption of advanced closure technologies. Major trends in the forecast period include increasing adoption of suture-based closure devices, rising preference for radial access closure solutions, growing use of bioabsorbable hemostatic materials, expansion of minimally invasive vascular procedures, enhanced focus on faster patient recovery.
The rising prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the arteriotomy closure devices market in the coming years. CVDs encompass a range of disorders that impact the heart and blood vessels. The growing incidence of CVDs is primarily due to increasing risk factors such as poor diets, lack of physical activity, obesity, and an aging population. Arteriotomy closure devices play a critical role in cardiovascular procedures by efficiently sealing arterial puncture sites, reducing the risk of complications, and enhancing recovery after treatments such as angioplasties and catheterizations. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research organization, reported that around 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. This number is expected to rise by an additional 1 million by 2030 and may increase by up to 2 million by 2040. As a result, the growing prevalence of cardiovascular diseases is driving the expansion of the arteriotomy closure devices market.
Leading companies in the arteriotomy closure devices market are focusing on innovation to improve procedural efficiency, enhance patient outcomes, and address the growing demand for minimally invasive vascular access solutions. A mid-bore venous closure device is a medical instrument designed to close venous access sites created by medium-sized catheters or sheaths, helping with hemostasis and supporting patient recovery after interventional procedures. For example, in June 2024, Haemonetics Corp, a US-based healthcare firm, expanded its VASCADE product line by introducing the VASCADE MVP XL mid-bore venous closure device. This device is designed for larger sheaths (10-12F, up to 15F outer diameter) commonly used in procedures such as cryoablation. It features 58% more collagen and a bigger collapsible disc to facilitate rapid hemostasis. This addition to Haemonetics' portfolio of small- and mid-bore vascular closure solutions highlights the company’s leadership in advanced closure technology.
In January 2025, Kalteq Group, a Greece-based medical device distributor, entered into an exclusive partnership with Teleflex. Through this partnership, Kalteq Group will distribute the MANTA Vascular Closure Device in Greece, broadening access to advanced large-bore femoral arterial closure solutions that enhance procedural efficiency and patient outcomes. Teleflex, Inc. is a U.S.-based company that provides arteriotomy closure devices.
Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical.
North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arteriotomy closure devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the arteriotomy closure devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the arteriotomy closure devices market by increasing costs of imported medical polymers, bioabsorbable materials, precision manufacturing tools, and sterile packaging components. Hospitals and ambulatory care centers in North America and Europe are most affected due to dependence on imported device components, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are increasing procedural costs and device pricing pressures. However, they are also encouraging domestic production, localized supply chains, and innovation in cost-effective vascular closure solutions.
The arteriotomy closure devices market research report is one of a series of new reports that provides arteriotomy closure devices market statistics, including arteriotomy closure devices industry global market size, regional shares, competitors with a arteriotomy closure devices market share, detailed arteriotomy closure devices market segments, market trends and opportunities, and any further data you may need to thrive in the arteriotomy closure devices industry. This arteriotomy closure devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An arteriotomy closure device (ACD) is a specialized medical tool intended to seal the puncture site in an artery after procedures such as catheterization or angiography. It helps achieve hemostasis by closing the artery, minimizing the risk of bleeding, and promoting a quicker recovery compared to manual compression. ACDs are frequently employed in minimally invasive vascular procedures to improve both patient safety and the efficiency of the procedure.
Arteriotomy closure devices primarily come in two types, active closure devices and passive closure devices. Active closure devices are used to close arterial puncture sites following medical procedures, employing mechanical or mechanical-hemostatic techniques to stop bleeding and support faster recovery. These devices are used in various procedures, including those involving femoral and radial arterial access, and are employed by a variety of healthcare settings, such as hospitals, outpatient care centers, and other medical facilities.
The arteriotomy closure devices market consists of sales of angiograms, catheterizations, and other interventional surgeries. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Arteriotomy Closure Devices Market Characteristics
3. Arteriotomy Closure Devices Market Supply Chain Analysis
4. Global Arteriotomy Closure Devices Market Trends and Strategies
5. Arteriotomy Closure Devices Market Analysis of End Use Industries
7. Global Arteriotomy Closure Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Arteriotomy Closure Devices Total Addressable Market (TAM) Analysis for the Market
9. Arteriotomy Closure Devices Market Segmentation
10. Arteriotomy Closure Devices Market Regional and Country Analysis
11. Asia-Pacific Arteriotomy Closure Devices Market
12. China Arteriotomy Closure Devices Market
13. India Arteriotomy Closure Devices Market
14. Japan Arteriotomy Closure Devices Market
15. Australia Arteriotomy Closure Devices Market
16. Indonesia Arteriotomy Closure Devices Market
17. South Korea Arteriotomy Closure Devices Market
18. Taiwan Arteriotomy Closure Devices Market
19. South East Asia Arteriotomy Closure Devices Market
20. Western Europe Arteriotomy Closure Devices Market
21. UK Arteriotomy Closure Devices Market
22. Germany Arteriotomy Closure Devices Market
23. France Arteriotomy Closure Devices Market
24. Italy Arteriotomy Closure Devices Market
25. Spain Arteriotomy Closure Devices Market
26. Eastern Europe Arteriotomy Closure Devices Market
27. Russia Arteriotomy Closure Devices Market
28. North America Arteriotomy Closure Devices Market
29. USA Arteriotomy Closure Devices Market
30. Canada Arteriotomy Closure Devices Market
31. South America Arteriotomy Closure Devices Market
32. Brazil Arteriotomy Closure Devices Market
33. Middle East Arteriotomy Closure Devices Market
34. Africa Arteriotomy Closure Devices Market
36. Arteriotomy Closure Devices Market Competitive Landscape and Company Profiles
37. Arteriotomy Closure Devices Market Other Major and Innovative Companies
40. Arteriotomy Closure Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Arteriotomy Closure Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses arteriotomy closure devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for arteriotomy closure devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The arteriotomy closure devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Active Closure Devices; Passive Closure Devices2) By Application: Femoral Arterial Access Procedures; Radial Arterial Access Procedures
3) By End User: Hospitals; Ambulatory Care Centers; Other End Users
Subsegments:
1) By Active Closure Devices: Suture-Based Devices; Staple-Based Devices; Vascular Closure Devices With Collagen Or Hemostatic Agents; Balloon-Based Devices2) By Passive Closure Devices: Compression Devices; Hemostatic Patches Or Sponges; Vascular Plugs Or Plugs
Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson; Abbott Laboratories; Medtronic PLC; Terumo Corporation; Teleflex Incorporated; Cook Medical Incorporated; Lepu Medical Technology (Beijing) Co. Ltd.; Meril Life Sciences Pvt. Ltd.; Haemonetics Corporation; Cordis Corporation; Asahi Intecc Co. Ltd.; LeMaitre Vascular Inc.; Cardiva Medical Inc.; AccessClosure Inc.; Vasorum Limited; Invamed (Pty) Ltd.; Artio Medical Inc.; SUTUREGARD Medical Inc.; Vivasure Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Arteriotomy Closure Devices market report include:- Cardinal Health Inc.
- Johnson & Johnson
- Abbott Laboratories
- Medtronic PLC
- Terumo Corporation
- Teleflex Incorporated
- Cook Medical Incorporated
- Lepu Medical Technology (Beijing) Co. Ltd.
- Meril Life Sciences Pvt. Ltd.
- Haemonetics Corporation
- Cordis Corporation
- Asahi Intecc Co. Ltd.
- LeMaitre Vascular Inc.
- Cardiva Medical Inc.
- AccessClosure Inc.
- Vasorum Limited
- Invamed (Pty) Ltd.
- Artio Medical Inc.
- SUTUREGARD Medical Inc.
- Vivasure Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.84 Billion |
| Forecasted Market Value ( USD | $ 2.38 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
